Travere Therapeutics
TVTX
#4650
Rank
C$2.17 B
Marketcap
$24.45
Share price
5.57%
Change (1 day)
227.32%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2023 (TTM): -$6.10

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.27. In 2022 the company made an earnings per share (EPS) of -$6.06 a decrease over its 2021 EPS that were of -$4.20.

EPS history for Travere Therapeutics from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.100.71%
2022-$6.0644.22%
2021-$4.20-10.09%
2020-$4.67-2.6%
2019-$4.8036.22%
2018-$3.5264.94%
2017-$2.1420.31%
2016-$1.77-135.46%
2015$5.01-175.68%
2014-$6.6198.75%
2013-$3.331746.15%
2012-$0.181.34%
2011-$0.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.39-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.37-94.03%๐Ÿ‡บ๐Ÿ‡ธ USA